Yoshida, Kazunari http://orcid.org/0000-0002-1965-9484
Marshe, Victoria S.
Elsheikh, Samar S. M.
Maciukiewicz, Malgorzata
Tiwari, Arun K. http://orcid.org/0000-0001-9209-2456
Brandl, Eva J.
Lieberman, Jeffrey A.
Meltzer, Herbert Y. http://orcid.org/0000-0003-4901-8845
Kennedy, James L. http://orcid.org/0000-0002-8733-3806
Müller, Daniel J. http://orcid.org/0000-0003-4978-4400
Article History
Received: 12 October 2022
Revised: 20 January 2023
Accepted: 30 March 2023
First Online: 27 April 2023
Competing interests
: KY has received paper fees from Sumitomo Dainippon Pharma, Brain & Behavior Research Foundation: Young Investigator Grant 2021, and Discovery Fund at CAMH within the past 3 years. AKT is a co-inventor on a patent for antipsychotic-induced weight gain (U.S. patent no. 10,662,475). EJB has received speaker fees from Medice. JAL is a member of the advisory boards of Boehringer Ingelheim and EdenRoc Sciences. HYM has received grant support from the National Institute of Mental Health, ACADIA, Eli Lilly, Neurocrine, Sepracor, Dainippon Sumitomo, and Janssen. JLK is a member of the Scientific Advisory Board of Myriad Neuroscience(unpaid) and holds several patents relating to pharmacogenetic tests for psychiatric medications. The other authors have nothing to disclose.